Drug information for STELAZINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CONCENTRATE; ORAL
EQ 10MG BASE/ML
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
11552
2003-02-04 Review
2001-04-03 Letter
INJECTABLE; INJECTION
EQ 2MG BASE/ML
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
"
TABLET; ORAL
EQ 10MG BASE
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
"
TABLET; ORAL
EQ 1MG BASE
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
"
TABLET; ORAL
EQ 2MG BASE
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
"
TABLET; ORAL
EQ 5MG BASE
Discontinued
TRIFLUOPERAZINE HYDROCHLORIDE
Trifluoperazine
GLAXOSMITHKLINE
"
Drug Adverse Effects information for STELAZINE
Role code
Indications
Reaction
# Reports
C
ARTHRITIS
CONSTIPATION
2
C
ARTHRITIS
GOUT
2
C
ARTHRITIS
URINARY INCONTINENCE
2
C
ARTHROPATHY
CONSTIPATION
2
C
ARTHROPATHY
GOUT
2
C
ARTHROPATHY
URINARY INCONTINENCE
2
C
BIPOLAR DISORDER
BLOOD CHOLESTEROL INCREASED
1
C
BIPOLAR DISORDER
BLOOD TRIGLYCERIDES INCREASED
1
C
BIPOLAR DISORDER
BLOOD URINE PRESENT
1
C
BIPOLAR DISORDER
BRONCHITIS
1
C
BIPOLAR DISORDER
CATARACT
1
C
BIPOLAR DISORDER
CHEST PAIN
1
C
BIPOLAR DISORDER
DIABETES MELLITUS
1
C
BIPOLAR DISORDER
HYPERTENSION
1
C
BIPOLAR DISORDER
RENAL FAILURE
1
C
BIPOLAR DISORDER
WEIGHT INCREASED
1
C
BLADDER DISORDER
CONSTIPATION
2
C
BLADDER DISORDER
GOUT
2
C
BLADDER DISORDER
URINARY INCONTINENCE
2
C
CARDIAC DISORDER
CONSTIPATION
2
C
CARDIAC DISORDER
GOUT
2
C
CARDIAC DISORDER
URINARY INCONTINENCE
2
C
CARDIAC FAILURE
CONSTIPATION
2
C
CARDIAC FAILURE
GOUT
2
C
CARDIAC FAILURE
URINARY INCONTINENCE
2
C
DEPRESSION
CONSTIPATION
2
C
DEPRESSION
FATIGUE
1
C
DEPRESSION
GOUT
2
C
DEPRESSION
INSOMNIA
1
C
DEPRESSION
MIGRAINE
1
C
DEPRESSION
URINARY INCONTINENCE
2
C
HYPERTENSION
CONSTIPATION
6
C
HYPERTENSION
GOUT
6
C
HYPERTENSION
URINARY INCONTINENCE
6
C
MACULAR DEGENERATION
CONSTIPATION
2
C
MACULAR DEGENERATION
GOUT
2
C
MACULAR DEGENERATION
URINARY INCONTINENCE
2
C
MICTURITION DISORDER
CONSTIPATION
2
C
MICTURITION DISORDER
GOUT
2
C
MICTURITION DISORDER
URINARY INCONTINENCE
2
C
MIGRAINE
FATIGUE
1
C
MIGRAINE
INSOMNIA
1
C
MIGRAINE
MIGRAINE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
AGGRESSION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HEADACHE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
PRURITUS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
SWELLING
1
C
SCHIZOPHRENIA
ANAEMIA
2
C
SCHIZOPHRENIA
ARTERIAL OCCLUSIVE DISEASE
1
C
SCHIZOPHRENIA
ASTHMA
1
C
SCHIZOPHRENIA
BRONCHITIS
1
C
SCHIZOPHRENIA
CEREBROVASCULAR ACCIDENT
2
C
SCHIZOPHRENIA
CHEST DISCOMFORT
1
C
SCHIZOPHRENIA
DEATH
1
C
SCHIZOPHRENIA
DEPRESSION
2
C
SCHIZOPHRENIA
DIABETES MELLITUS
3
C
SCHIZOPHRENIA
DIABETIC KETOACIDOSIS
2
C
SCHIZOPHRENIA
FATIGUE
2
C
SCHIZOPHRENIA
HYPERSOMNIA
2
C
SCHIZOPHRENIA
MEMORY IMPAIRMENT
2
C
SCHIZOPHRENIA
MENTAL IMPAIRMENT
2
C
SCHIZOPHRENIA
NEOPLASM MALIGNANT
1
C
SCHIZOPHRENIA
NEUTROPHIL COUNT INCREASED
1
C
SCHIZOPHRENIA
OEDEMA PERIPHERAL
2
C
SCHIZOPHRENIA
OVERDOSE
2
C
SCHIZOPHRENIA
PANCREATITIS
2
C
SCHIZOPHRENIA
PYREXIA
2
C
SCHIZOPHRENIA
RENAL FAILURE
2
C
SCHIZOPHRENIA
THROMBOCYTOPENIA
2
C
SCHIZOPHRENIA
WHITE BLOOD CELL COUNT INCREASED
1
I
PARKINSON'S DISEASE
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
I
PARKINSON'S DISEASE
DRUG INTERACTION
1
I
PARKINSON'S DISEASE
NEUROLEPTIC MALIGNANT SYNDROME
1
I
PARKINSON'S DISEASE
SCHIZOPHRENIA
1
I
PARKINSON'S DISEASE
SEDATION
1
I
SCHIZOPHRENIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
I
SCHIZOPHRENIA
DRUG INTERACTION
1
I
SCHIZOPHRENIA
NEUROLEPTIC MALIGNANT SYNDROME
1
I
SCHIZOPHRENIA
SCHIZOPHRENIA
1
I
SCHIZOPHRENIA
SEDATION
1
Ads by Google